These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8071484

  • 1. Nutritional implications of recombinant human erythropoietin therapy in renal disease.
    Sanders HN, Rabb HA, Bittle P, Ramirez G.
    J Am Diet Assoc; 1994 Sep; 94(9):1023-9. PubMed ID: 8071484
    [Abstract] [Full Text] [Related]

  • 2. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 3. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA.
    Semin Nephrol; 1989 Mar 15; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [Abstract] [Full Text] [Related]

  • 4. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A, Barrau J, Gómez Alamillo C, Jaurrieta F.
    Sangre (Barc); 1990 Feb 15; 35(1):82-4. PubMed ID: 2333585
    [Abstract] [Full Text] [Related]

  • 5. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
    Van Wyck DB.
    Semin Nephrol; 1989 Mar 15; 9(1 Suppl 2):21-4. PubMed ID: 2669082
    [Abstract] [Full Text] [Related]

  • 6. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
    Akizawa T, Koshikawa S, Takaku F, Urabe A, Akiyama N, Mimura N, Otsubo O, Nihei H, Suzuki Y, Kawaguchi Y.
    Int J Artif Organs; 1988 Sep 15; 11(5):343-50. PubMed ID: 3056862
    [Abstract] [Full Text] [Related]

  • 7. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 15; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
    Kuo CC, Lee CT, Chuang CH, Su Y, Chen JB.
    Clin Nephrol; 2005 Feb 15; 63(2):92-7. PubMed ID: 15730050
    [Abstract] [Full Text] [Related]

  • 9. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I, Lavoratti GC, Materassi M, Burgio G, Bartolozzi G.
    Pediatr Med Chir; 1991 Feb 15; 13(5):475-7. PubMed ID: 1788107
    [Abstract] [Full Text] [Related]

  • 10. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial.
    Kleinman KS, Schweitzer SU, Perdue ST, Bleifer KH, Abels RI.
    Am J Kidney Dis; 1989 Dec 15; 14(6):486-95. PubMed ID: 2688405
    [Abstract] [Full Text] [Related]

  • 11. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A, Reyes A, Valdés F, Otero A, López de Novales E, Pallardó L, Tabernero JM, Hernández Jaras J, Lladós F.
    Nefrologia; 2003 Dec 15; 23(2):114-24. PubMed ID: 12778875
    [Abstract] [Full Text] [Related]

  • 12. Iron management during recombinant human erythropoietin therapy.
    Van Wyck DB.
    Am J Kidney Dis; 1989 Aug 15; 14(2 Suppl 1):9-13. PubMed ID: 2757026
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA, Verberckmoes R, Michielsen P, Koene RA.
    Nephrol Dial Transplant; 1989 Aug 15; 4(9):782-6. PubMed ID: 2516609
    [Abstract] [Full Text] [Related]

  • 14. [Management of renal anemia in 2013].
    Gianella P, Martin PY, Stucker F.
    Rev Med Suisse; 2013 Feb 27; 9(375):462-4, 466-7. PubMed ID: 23539813
    [Abstract] [Full Text] [Related]

  • 15. Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.
    Stone WJ, Graber SE, Krantz SB, Dessypris EN, O'Neil VL, Olsen NJ, Pincus TP.
    Am J Med Sci; 1988 Sep 27; 296(3):171-9. PubMed ID: 3177433
    [Abstract] [Full Text] [Related]

  • 16. Iron metabolism and iron substitution during erythropoietin therapy.
    Sunder-Plassmann G, Hörl WH.
    Clin Investig; 1994 Sep 27; 72(6 Suppl):S11-5. PubMed ID: 7950165
    [Abstract] [Full Text] [Related]

  • 17. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
    Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW, Shadur CA.
    Am J Kidney Dis; 1994 Nov 27; 24(5):777-84. PubMed ID: 7977319
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 19. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin.
    Adamson JW, Eschbach JW.
    Annu Rev Med; 1990 Dec 13; 41():349-60. PubMed ID: 2184735
    [Abstract] [Full Text] [Related]

  • 20. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C, Boquinhas H, Gaspar A, Adragão T, Boquinhas JM, Júnior EC, Simões J.
    Acta Med Port; 1992 Jul 13; 5(7):351-7. PubMed ID: 1442178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.